Safety and Efficacy of rAAV.hCNGA3 Gene Therapy in Patients With CNGA3-linked Achromatopsia
Clinical trial NCT02610582 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02610582
- Sponsor
- STZ eyetrial
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-01
- Primary completion
- 2027-06-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.